Literature DB >> 26300237

Co-existence of insulin resistance and high concentrations of circulating oxidized LDL lipids.

Meri S Linna1, Markku Ahotupa, Katriina Kukkonen-Harjula, Mikael Fogelholm, Tommi J Vasankari.   

Abstract

INTRODUCTION: Insulin metabolism has been previously linked to oxidized low-density lipoproteins (ox-LDL), but corroborating intervention studies are lacking. We investigated whether changes in ox-LDL levels are accompanied by changes in insulin sensitivity in a 32-month life-style intervention study.
MATERIALS AND METHODS: A 2-month weight reduction was followed by 6-month diet and exercise counselling and a 2-year follow-up period. Men of 35-50 years of age, BMI ≥ 30 kg/m(2), and waist circumference > 100 cm were recruited via newspapers in the city of Tampere, Finland. Of the 90 men meeting the inclusion criteria, 67 (76%) completed the study. Ox-LDL was estimated as the presence of oxidized lipids in LDL. Homeostasis model assessment of insulin resistance (HOMA-IR), ox-LDL, and ratio of ox-LDL and high-density lipoprotein cholesterol (ox-LDL/HDL-c) were used as the main outcome measures.
RESULTS: The detected changes in HOMA-IR were strikingly similar to those in ox-LDL and ox-LDL/HDL-c. Compared to the first HOMA-IR quartile, the fourth quartile had 23%-51% higher concentrations in ox-LDL and ox-LDL/HDL-c at all time points (P < 0.05 for all).
CONCLUSION: This weight reduction intervention study adds evidence to support the connection between insulin metabolism and oxidized LDL, possibly contributing to the higher incidence of atherosclerotic cardiovascular diseases among diabetic patients.

Entities:  

Keywords:  Atherosclerosis; insulin resistance; life-style; oxidized low-density lipoprotein; risk factors

Mesh:

Substances:

Year:  2015        PMID: 26300237     DOI: 10.3109/07853890.2015.1043939

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  6 in total

1.  The Effects of 3 Weeks of Uphill and Downhill Walking on Blood Lipids and Glucose Metabolism in Pre-Diabetic Men: A Pilot Study.

Authors:  Marc Philippe; Hannes Gatterer; Erika Maria Eder; Alexander Dzien; Matthias Somavilla; Andreas Melmer; Christoph Ebenbichler; Tom Müller; Martin Burtscher
Journal:  J Sports Sci Med       Date:  2017-03-01       Impact factor: 2.988

2.  Higher risk of hyperglycemia with greater susceptibility in females in chronic arsenic-exposed individuals in Bangladesh.

Authors:  Sudip Kumar Paul; Md Shofikul Islam; M M Hasibuzzaman; Faruk Hossain; Adiba Anjum; Zahangir Alam Saud; Md Mominul Haque; Papia Sultana; Azizul Haque; Klara Biljana Andric; Aminur Rahman; Md Rezaul Karim; Abu Eabrahim Siddique; Yeasir Karim; Mizanur Rahman; Hideki Miyataka; Lian Xin; Seiichiro Himeno; Khaled Hossain
Journal:  Sci Total Environ       Date:  2019-03-04       Impact factor: 7.963

Review 3.  The Contribution of Singlet Oxygen to Insulin Resistance.

Authors:  Arnold N Onyango
Journal:  Oxid Med Cell Longev       Date:  2017-09-07       Impact factor: 6.543

4.  Dietary Annatto-Extracted Tocotrienol Reduces Inflammation and Oxidative Stress, and Improves Macronutrient Metabolism in Obese Mice: A Metabolic Profiling Study.

Authors:  Chwan-Li Shen; Sivapriya Ramamoorthy; Gurvinder Kaur; Jannette M Dufour; Rui Wang; Huanbiao Mo; Bruce A Watkins
Journal:  Nutrients       Date:  2021-04-13       Impact factor: 5.717

Review 5.  Pathophysiological Commonality Between Irritable Bowel Syndrome and Metabolic Syndrome: Role of Corticotropin-releasing Factor-Toll-like Receptor 4-Proinflammatory Cytokine Signaling.

Authors:  Tsukasa Nozu; Toshikatsu Okumura
Journal:  J Neurogastroenterol Motil       Date:  2022-04-30       Impact factor: 4.924

6.  Increased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver disease.

Authors:  Dan-Qin Sun; Wen-Yue Liu; Sheng-Jie Wu; Gui-Qi Zhu; Martin Braddock; Dong-Chu Zhang; Ke-Qing Shi; Dan Song; Ming-Hua Zheng
Journal:  Oncotarget       Date:  2016-02-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.